Literature DB >> 11514475

Late acute thrombosis after paclitaxel eluting stent implantation.

F Liistro1, A Colombo.   

Abstract

Late (more than six months) total occlusion after coronary stenting is a progressive phenomenon occurring in approximately 4% of patients, leading to acute myocardial infarction in less than 0.5%. The process must be related to severe and progressive intimal hyperplasia. In patients receiving coronary stenting with simultaneous brachytherapy, late total occlusion has been reported at a higher rate and to be related to stent thrombosis rather than intimal hyperplasia. Late total occlusion presenting with an acute clinical event seven months after the implantation of a paclitaxel drug eluting stent is reported. The occlusion developed soon after the interruption of ticlopidine treatment, suggesting that the event had a thrombotic genesis and that the risk is not confined to the first six month period.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514475      PMCID: PMC1729898          DOI: 10.1136/heart.86.3.262

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  15 in total

1.  Notch signaling regulates endothelial progenitor cell activity during recovery from arterial injury in hypercholesterolemic mice.

Authors:  Masaaki Ii; Kyosuke Takeshita; Kayoko Ibusuki; Corinne Luedemann; Andrea Wecker; Elizabeth Eaton; Tina Thorne; Takayuki Asahara; James K Liao; Douglas W Losordo
Journal:  Circulation       Date:  2010-02-22       Impact factor: 29.690

Review 2.  Coronary stents: in these days of climate change should all stents wear coats?

Authors:  R Lowe; I B A Menown; G Nogareda; I M Penn
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

Review 3.  Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents.

Authors:  Marco Zimarino; Giulia Renda; Raffaele De Caterina
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  A prospective, multi-centric, observational registry to evaluate performance of Excel™ DES in 'real world, all comers' patient population.

Authors:  Shirish Hiremath; Praveen Chandra; Devang Desai; R Sivakumar; S Selvamani; Anand Srinivasan; Madhu Paulose; Sajy Jose; B C Kalmath; Vilas P Magarkar; Abhijeet Pathak; Tushar Mhetre
Journal:  Indian Heart J       Date:  2014-12-23

5.  Granulation encapsulated stent: a new therapeutic approach for vascular implantation.

Authors:  Lilong Tang; Xiaochao Chen; Shuangbo Tang; Thomas LaLonde; Julius M Gardin
Journal:  Heart       Date:  2006-08-16       Impact factor: 5.994

6.  Investigation of PLLA/PCL blends and paclitaxel release profiles.

Authors:  Erde Can; Gokce Udenir; Ayse Irem Kanneci; Gamze Kose; Seyda Bucak
Journal:  AAPS PharmSciTech       Date:  2011-10-25       Impact factor: 3.246

7.  Acute myocardial infarction caused by thrombotic occlusion at a stent site two years after conventional stent implantation.

Authors:  T Hayashi; A Kimura; K Ishikawa
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

8.  A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score.

Authors:  Davide Capodanno; Piera Capranzano; Rita Bucalo; Alessandra Sanfilippo; Cettina Ruperto; Anna Caggegi; Gianpaolo Ussia; Alfredo Ruggero Galassi; Corrado Tamburino
Journal:  Clin Res Cardiol       Date:  2009-02-13       Impact factor: 5.460

Review 9.  Drug-eluting stents: new era and new concerns.

Authors:  V Bhatia; R Bhatia; M Dhindsa
Journal:  Postgrad Med J       Date:  2004-01       Impact factor: 2.401

Review 10.  Drug eluting stents: are human and animal studies comparable?

Authors:  R Virmani; F D Kolodgie; A Farb; A Lafont
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.